reports
- Rayhan Ahmed
Equity Note on Beximco Pharmaceuticals Limited (BXPHARMA)
Beximco Pharmaceuticals Limited (BXPHARMA) is a leading manufacturer and seller of generic pharmaceutical formulation products for both domestic and international markets. The company produces over 300 generic medicines, which are available in more than 500 different presentations, covering key therapeutic classes such as antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, gastrointestinal etc. Additionally, the company manufactures Active Pharmaceutical ...
- Mohammad Rehan Kabir
Equity Note on Beximco Pharmaceuticals Ltd.
Beximco Pharmaceuticals Ltd. Is among the top 10 manufacturer of tablets, capsules, intravenous fluids, liquids, creams, ointments, suppositories, metered dose inhalers, ophthalmic drops and injections in Bangladesh. They currently produces more than 300 generic medicines which are available in well over 500 different presentations and the broad portfolio encompasses all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous syst...
- Mohammad Rehan Kabir
Equity Insight on Beximco Pharmaceuticals Limited
​Beximco Pharmaceuticals Ltd (BXPHARMA) is an emerging generic drug provider from Bangladesh committed to providing access to affordable medicines. Company currently holds 8.43% (3rd in the country) market share and produces more than 300 generic medicines which are available in well over 500 different presentations. Company's broad portfolio encompasses all key therapeutic categories including antibiotics, analgesics, anti-diabetic, respiratory, cardiovascular, central nervous system, derm...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.